LifeScience Clinical & Diagnostic
Everest Medicines Eyes Strategic Asia Expansion With Proposed Hasten Singapore Acquisition
Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing, a...
March 19, 2026 | News
Viva Biotech Advances ActRIIA Targeted Mini Binder Discovery With AI Driven Proteina Complexa Optimisation
Viva Biotech (01873.HK) optimizes the Proteina-Complexa model in advancing the design of mini-binders targeting ActRIIA, a receptor critical...
March 18, 2026 | News
Viva Biotech Advances ActRIIA Targeted Mini Binder Discovery With AI Driven Proteina Complexa Optimisation
Viva Biotech (01873.HK) optimizes the Proteina-Complexa model in advancing the design of mini-binders targeting ActRIIA, a receptor critical...
March 18, 2026 | News
Viva Biotech Advances ActRIIA Targeted Mini Binder Discovery With AI Driven Proteina Complexa Optimisation
Viva Biotech (01873.HK) optimizes the Proteina-Complexa model in advancing the design of mini-binders targeting ActRIIA, a receptor critical...
March 18, 2026 | News
Alphamab Oncology Doses First Patient In Global Phase I Trial Of First PD L1 VEGFR2 Bispecific ADC
Alphamab Oncology (stock code: 9966.HK) announced that the first patient has been successfully dosed in the phase I clinical study (study code: JSKN027-101...
March 18, 2026 | News
Alebund Partners R1 Therapeutics To Advance AP306 Globally For CKD Related Hyperphosphatemia
AP306 is a first-in-class pan-phosphate transporter inhibitor in development for the treatment of hyperphosphatemia in patients with chronic kidney disease...
March 18, 2026 | News
Telix Resubmits US NDA For Pixclara PET Imaging Agent Targeting Glioma Diagnosis
Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") announces the resubmission of a New Drug Application (NDA) to the United States (U.S.) Food ...
March 17, 2026 | News
Akeso Secures China IND Clearance For First In Class Trispecific Antibody AK150 Targeting Solid Tumours
Akeso, Inc. (9926.HK) ("Akeso" or the "Company") announced that its proprietary first-in-class trispecific antibody, AK150 (ILT2/ILT4/CSF1R), has rec...
March 17, 2026 | News
Vimgreen Pharmaceuticals Secures China IND Approval For VG081821 In NASH Clinical Development
Vimgreen Pharmaceuticals, a leading innovator in adenosine signaling modulation, announced the approval of its Investigational New Drug (IND) application f...
March 16, 2026 | News
GenScript Opens First European mRNA Production Facility In Delft Strengthening Global Biotechnology Platform
Strategic investment reinforces Europe as a core pillar of GenScript's global R&D and production network, following recent U.S. facility...
March 13, 2026 | News
Meiji Seika Pharma Initiates Phase I Trial Of ME3241 PD 1 Agonist Antibody For Autoimmune Diseases
Meiji Seika Pharma Co., Ltd. (Headquarters: Chuo-ku, Tokyo, Japan; President and Representative Director: Toshiaki Nagasato) announced that it has in...
March 12, 2026 | News
Everest Medicines Launches VELSIPITY Oral Therapy For Ulcerative Colitis In Mainland China
Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing an...
March 11, 2026 | News
Codex Genetics And C2N Diagnostics Partner To Expand Alzheimer’s Blood Test Access In Hong Kong
Codex Genetics, a leading precision diagnostics company headquartered in Hong Kong, today announces a strategic collaboration with C2N Diagnostics (C2N), a...
March 11, 2026 | News
Leads Biolabs Doses First Patient In Phase II Trial Of PD L1 4 1BB Bispecific Antibody For Esophageal Cancer
Nanjing Leads Biolabs Co., Ltd. ("Leads Biolabs" or the "Company," Stock Code: 9887.HK) announced on March 6, 2026 that the first patient has bee...
March 10, 2026 | News
Most Read
- How Does GLP-1 Work?
- Innovations In Magnetic Resonance Imaging Introduced By United Imaging
- Management of Relapsed/Refractory Multiple Myeloma
- 2025 Drug Approvals, Decoded: What Every Biopharma Leader Needs to Know
- BioPharma Manufacturing Resilience: Lessons From Capacity Expansion and Supply Chain Resets from 2025
- APAC Biopharma Review 2025: Innovation, Investment, and Influence on the Global Stage
- Top 25 Biotech Innovations Redefining Health And Planet In 2025
- The New AI Gold Rush: Western Pharma’s Billion-Dollar Bet on Chinese Biotech
- Single-Use Systems Are Rewiring Biopharma Manufacturing
- The State of Biotech and Life Science Jobs in Asia Pacific – 2025
- Asia-Pacific Leads the Charge: Latest Global BioSupplier Technologies of 2025
- Invisible Threats, Visible Risks: How the Nitrosamine Crisis Reshaped Asia’s Pharmaceutical Quality Landscape
Bio Jobs
- Sanofi Turns The Page As Belén Garijo Steps In And Paul Hudson Steps Out
- Global Survey Reveals Nearly 40% of Employees Facing Fertility Challenges Consider Leaving Their Jobs
- BioMed X and AbbVie Begin Global Search for Bold Neuroscience Talent To Decode the Biology of Anhedonia
- Thermo Fisher Expands Bengaluru R&D Centre to Advance Antibody Innovation and Strengthen India’s Life Sciences Ecosystem
- Accord Plasma (Intas Group) Acquires Prothya Biosolutions to Expand Global Plasma Capabilities
- ACG Announces $200 Million Investment to Establish First U.S. Capsule Manufacturing Facility in Atlanta
- AstraZeneca Invests $4.5 Billion to Build Advanced Manufacturing Facility in Virginia, Expanding U.S. Medicine Production
News
